Sanofi向Medix电台和Orano Med电台的下一代放射和癌症治疗技术发放许可证。 Sanofi licenses next-gen radioligand cancer treatment tech from RadioMedix and Orano Med.

赛诺菲与RadioMedix和Orano Med签署了一项许可协议,开发一代放射性体药物,用于治疗罕见癌症. Sanofi has entered a licensing agreement with RadioMedix and Orano Med to develop a next-generation radioligand medicine aimed at treating rare cancers. 这一合作旨在为面临这些困难条件的病人提出创新的治疗方案。 This collaboration seeks to advance innovative treatment options for patients facing these challenging conditions.